iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Lancet Oncol. 2017 Mar;18(3):e143-e152. doi: 10.1016/S1470-2045(17)30074-8. Epub 2017 Mar 2.
Lancet Oncol. 2017.
PMID: 28271869
Free PMC article.
Review.